We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

208 hedge funds and large institutions have $2.85B invested in Ariad Pharmaceuticals Inc in 2013 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 83 increasing their positions, 62 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 21

34% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 62

6% more capital invested

Capital invested by funds: $2.69B → $2.85B (+$164M)

5% more funds holding

Funds holding: 198 → 208 (+10)

43% less call options, than puts

Call options by funds: $21.9M | Put options by funds: $38.3M

60% less funds holding in top 10

Funds holding in top 10: 5 → 2 (-3)

Holders
208
Holders Change
+10
Holders Change %
+5.05%
% of All Funds
6.74%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.06%
New
34
Increased
83
Reduced
62
Closed
21
Calls
$21.9M
Puts
$38.3M
Net Calls
-$16.4M
Net Calls Change
-$16.5M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$64.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$44.7M
3
Norges Bank
Norges Bank
Norway
+$34.8M
4
BA
BlackRock Advisors
Delaware
+$31.1M
5
Goldman Sachs
Goldman Sachs
New York
+$30.2M

Top Sellers

Rank Fund Capital Flow
1
Artisan Partners
Artisan Partners
Wisconsin
-$135M
2
TCM
TimesSquare Capital Management
New York
-$62.9M
3
JHIU
Janus Henderson Investors US
Colorado
-$55.7M
4
SAM
Sectoral Asset Management
Quebec, Canada
-$44.3M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$30.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
101
STRS Ohio
Ohio
$2.02M +$2.14M +110,000 New
DekaBank Deutsche Girozentrale
102
DekaBank Deutsche Girozentrale
Germany
$1.9M +$2M +103,200 New
VOYA Investment Management
103
VOYA Investment Management
Georgia
$1.78M -$4.12K -212 -0.2%
Los Angeles Capital Management
104
Los Angeles Capital Management
California
$1.78M +$276K +14,230 +17%
State Farm Mutual Automobile Insurance
105
State Farm Mutual Automobile Insurance
Illinois
$1.59M – – –
STC
106
SEI Trust Company
Pennsylvania
$1.48M +$8.25K +425 +0.5%
AQR Capital Management
107
AQR Capital Management
Connecticut
$1.47M +$620K +31,926 +66%
Citigroup
108
Citigroup
New York
$1.46M +$1.27M +65,267 +467%
RNS
109
Robert N. Shapiro
$1.43M +$384K +19,764 +34%
ACPU
110
Arrowgrass Capital Partners (US)
Delaware
$1.4M +$1.48M +76,000 New
IRF
111
IBM Retirement Fund
New York
$1.4M -$191K -9,852 -11%
New York State Common Retirement Fund
112
New York State Common Retirement Fund
New York
$1.38M +$1.38M +71,144 +1,976%
ProShare Advisors
113
ProShare Advisors
Maryland
$1.3M +$584K +30,062 +74%
JG
114
Jefferies Group
New York
$1.29M +$271K +13,970 +25%
FSA
115
Franklin Street Advisors
North Carolina
$1.26M – – –
PPA
116
Parametric Portfolio Associates
Washington
$1.17M +$277K +14,245 +29%
CC
117
Curian Capital
Colorado
$1.15M +$20K +1,030 +2%
Macquarie Group
118
Macquarie Group
Australia
$1.09M +$214K +11,000 +23%
Ohio Public Employees Retirement System (OPERS)
119
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.05M +$444K +22,879 +67%
QIM
120
Quantitative Investment Management
Virginia
$1.05M +$1.11M +57,100 New
SCA
121
SAC Capital Advisors
Connecticut
$1.03M -$296K -15,270 -21%
PIM
122
Platinum Investment Management
Australia
$962K – – –
GH
123
GAM Holding
Switzerland
$957K +$1.01M +52,000 New
RB
124
Rodgers Brothers
Pennsylvania
$946K +$31.1K +1,600 +3%
MCM
125
Moore Capital Management
New York
$920K -$485K -25,000 -33%
3 4
5
6 7

ARIA Hedge Fund Activity: Q3 2013 in Review

208 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q3 2013, worth a combined $2.85B — up 6.1% from $2.69B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ARIA positions and 21 closed out — a net gain of 13 holders — while 83 added to existing stakes and 62 trimmed.

The largest buyer was Franklin Resources, adding an estimated $64.5M. The largest seller was Artisan Partners, cutting an estimated $135M.

  • 208 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q3 2013, up from 198 in Q2 2013.
  • Funds reported $2.85B of Ariad Pharmaceuticals Inc stock for Q3 2013, up 6.1% quarter-over-quarter.
  • 34 funds opened new Ariad Pharmaceuticals Inc positions in Q3 2013 and 21 closed out, a net change of +13 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q3 2013 was Franklin Resources, an estimated $64.5M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q3 2013 was Artisan Partners, an estimated $135M sold.

Based on aggregated 13F filings for Q3 2013.